Is Geron Corporation (GERN) Going to Burn These Hedge Funds?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Posts Tagged ‘NASDAQ:GERN’
Market Movers Today: Alnylam Pharmaceuticals, Inc. (ALNY), Snap Inc (SNAP), Sellas Life Sciences Group Inc (SLS), Intel Corporation (INTC), and More
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) (The Motley Fool) What happened: Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a precommercial pioneer...
Market Movers Today: Tesla Inc (TSLA), Amazon.com, Inc. (AMZN), Edge Therapeutics Inc (EDGE), Lululemon Athletica inc. (LULU), and More
Tesla Inc (NASDAQ:TSLA) (Reuters) NEW YORK, March 28 (Reuters) – Tesla Inc shares fell more than 9 percent on Wednesday following a downgrade by...
Market Movers Today: Dropbox, Inc. (DBX), Micron Technology, Inc. (MU), New York & Company, Inc. (NWY), Geron Corporation (GERN), and More
Dropbox, Inc. (NASDAQ:DBX) (Reuters) (Reuters) – Dropbox Inc’s shares soared by as much as 50 percent in their first day of trading on Friday...
Market Movers Today: Facebook, Inc. (FB), Geron Corporation (GERN), Heron Therapeutics Inc (HRTX), Micro Focus International PLC – ADR (MFGP), and More
Facebook, Inc. (NASDAQ:FB) (Los Angeles Times) Facebook Inc.’s stock tumbled Monday after the social media company accused a data analytics firm...
40 Fresh Stories to Know How is it Going in the Financial Markets Today
1. U.S. Stock Market: “U.S. equities traded mostly lower on Friday as investors digested a tough week for retailers as well as mixed economic...
What Is Happening In Financial Markets Today?
1. US Stock Market: “U.S. equities advanced slightly on Monday amid geopolitical tensions while investors looked ahead to the start of earnings...
Geron Corp. (GERN) Surging Amid Positive Reviews on Clinical Trials
Geron Corp. (NASDAQ:GERN) took a leap by 18.60% to $2.55 on April 10, amid announcing the completion of the second wave of reviews related to clinical...
Johnson & Johnson (JNJ)’s Janssen Builds On Partnership With Geron Corporation (GERN)
Janssen Pharmaceuticals, a subsidiary of the giant manufacturing company, Johnson & Johnson (NYSE:JNJ) has expanded the current partnership with...
Why Isle of Capri Casinos (ISLE) and KB Home (KBH) Are Among Today’s Gaining Stocks
Stock markets around the world rebounded with rise in oil prices and gains in commodity markets. Oil prices increased today after couple of weeks low...
Polaris, Syntel: Why These 5 Stocks Are Making Big Moves Today
After selling off by almost 4% on Friday, crude futures have bounced back today and are 0.74% in the green as investors anticipate the upcoming API report...
Here is What Hedge Funds Think About Geron Corporation (GERN)
Is Geron Corporation (NASDAQ:GERN) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research...
Geron Corporation (GERN) And Lannett Company, Inc. (LCI): Two Pharmaceutical Stocks Making Big Gains For Very Different Reasons
Shares of both Geron Corporation (NASDAQ:GERN) and Lannett Company, Inc. (NYSE:LCI) are in the limelight today as each has made significant gains on...
Wayne Holman’s Hedge Fund Takes 5.8% Stake in Geron
Wayne Holman, Geron Corporation: This morning, Wayne Holman‘s hedge fund Ridgeback Capital Management reported adding Geron Corporation (NASDAQ...
Aratana Therapeutics Inc (PETX), Geron Corporation (GERN), Kythera Biopharmaceuticals Inc (KYTH): Humongous Health-Care Stocks This Week
While the overall markets largely muddled along this week, some stocks kicked into high gear. Here are three of the week’s most humongous performers...
Should You Buy Pacific Biosciences of California (PACB)?
To the average investor, there are tons of metrics shareholders can use to analyze Mr. Market. A duo of the best are hedge fund and insider trading interest...
Is Pacific Biosciences of California (PACB) Going to Burn These Hedge Funds?
Pacific Biosciences of California (NASDAQ:PACB) was in 7 hedge funds’ portfolio at the end of the first quarter of 2013. PACB investors should be...
Do Hedge Funds and Insiders Love Geron Corporation (GERN)?
Is Geron Corporation (NASDAQ:GERN) a healthy stock for your portfolio? Money managers are in an optimistic mood. The number of long hedge fund bets moved...
Geron Corporation (GERN), STEC, Inc. (STEC): Only One of These Stocks Won’t Be a Winner
Think of it as the pause that refreshes. The Dow Jones Industrial Average 2 Minute (Dow Jones Indices:.DJI) finally broke its string of consecutive days...
What Is This CEO Doing to Earn $450 Per Hour? – Geron Corporation (GERN)
The questions from analysts at the end of a company’s conference call typically fall in the softball category. There’s often a lot of backslapping...
Geron Corporation (GERN) Earnings: An Early Look – BioTime, Inc. (BTX), StemCells, Inc. (STEM)
Earnings season is winding down, with most companies already having reported their quarterly results. But there are still some companies left to report...
StemCells, Inc. (STEM) Have a Long Way to Go: Sarepta Therapeutics Inc (SRPT)
StemCells, Inc. (NASDAQ:STEM) stock jumped more than 20% after the biotech released long-term data for its neural stem cell product HuCNS-SC, but investors...
